In a move that’s got investors buzzing, Keros Therapeutics (NASDAQ: KROS) has announced a review of…
Tag: Therapeutics
Sage Therapeutics: A Speculative Play That Needs To Wait For A Turnaround Story
Sage Therapeutics: A Speculative Play That Needs To Wait For A Turnaround Story #Sage #Therapeutics #Speculative…
Akero Therapeutics: Cirrhosis Reversal Data Derisks The Stock (NASDAQ:AKRO)
This article was written by Follow Avisol Capital Partners is made up of a team of…
Beam Therapeutics Presents Additional Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at 2025 Alpha-1 Foundation 7th Global Research Conference and 10th Patient Congress
Beam Therapeutics Presents Additional Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at 2025 Alpha-1 Foundation…
OrbiMed Advisors LLC purchases $10 million in Edgewise Therapeutics stock
OrbiMed Advisors LLC purchases $10 million in Edgewise Therapeutics stock#OrbiMed #Advisors #LLC #purchases #million #Edgewise #Therapeutics…
Bicycle therapeutics CTO Michael Skynner sells shares worth $14,292
Bicycle therapeutics CTO Michael Skynner sells shares worth $14,292#Bicycle #therapeutics #CTO #Michael #Skynner #sells #shares #worth
Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal
Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal #Sangamo #Therapeutics #Scope #Eli…
Pliant Therapeutics: An Activist On Deck
Pliant Therapeutics: An Activist On Deck #Pliant #Therapeutics #Activist #Deck
Zevra Therapeutics: Mixed Feelings On Miplyffa Approval
Zevra Therapeutics: Mixed Feelings On Miplyffa Approval #Zevra #Therapeutics #Mixed #Feelings #Miplyffa #Approval
Corcept therapeutics officer sells $20.2 million in stock
Corcept therapeutics officer sells $20.2 million in stock#Corcept #therapeutics #officer #sells #million #stock
Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ET Company…
Leap Therapeutics (LPTX) Conference Call to discuss Updated Data from Part B of the DeFianCe Study Transcript
Leap Therapeutics (LPTX) Conference Call to discuss Updated Data from Part B of the DeFianCe Study…
Corcept Therapeutics: A Stock on the Rise, But Is It a Buy?
As an investor, it’s always exciting to see a stock surge in value. And Corcept Therapeutics…
Soleno Therapeutics: A Breakthrough in Rare Disease Treatment
The biotech world is buzzing with excitement as Soleno Therapeutics (SLNO) has just received FDA approval…
CRISPR Therapeutics Set To Reach Previous Heights
CRISPR Therapeutics Set To Reach Previous Heights #CRISPR #Therapeutics #Set #Reach #Previous #Heights
Atossa Therapeutics, Inc. (ATOS) Q4 2024 Earnings Call Transcript
Atossa Therapeutics, Inc. (ATOS) Q4 2024 Earnings Call Transcript #Atossa #Therapeutics #ATOS #Earnings #Call #Transcript
Verve Therapeutics: HeFH Treatment Program Of VERVE-102 Remains On Track With 2025 Catalysts
Verve Therapeutics: HeFH Treatment Program Of VERVE-102 Remains On Track With 2025 Catalysts #Verve #Therapeutics #HeFH…
ADC Therapeutics: Promise Remains, But Fortunes Rest On Success Of Single Trial In 2025
ADC Therapeutics: Promise Remains, But Fortunes Rest On Success Of Single Trial In 2025 #ADC #Therapeutics…
Monte Rosa Therapeutics: Exercise Extreme Caution
Monte Rosa Therapeutics: Exercise Extreme Caution #Monte #Rosa #Therapeutics #Exercise #Extreme #Caution
Aquestive Therapeutics: Not For Me, But Attractive
Aquestive Therapeutics: Not For Me, But Attractive #Aquestive #Therapeutics #Attractive